Why in news ?
- Scientists at THSTI Faridabad developed a low-cost dipstick assay to detect antimicrobial resistance (AMR) genes in sewage, enabling rapid population-level surveillance in a major public health threat area.
- Study published in Nature Communications (Dec 2025) validated the test across 381 sewage sites in six Indian States, confirming sewage as a major AMR reservoir and transmission pathway.
- The assay costs only ₹400–550 per test, versus ₹9,000+ for shotgun sequencing, making large-scale AMR monitoring feasible for resource-constrained public health systems.
Relevance
- GS2 (Health): AMR policy, public health
- GS3 (Science & Tech): Biotechnology innovation
- GS3 (Environment): One Health, wastewater surveillance
Basics and background
- Antimicrobial resistance (AMR) occurs when microbes evolve mechanisms to survive drugs, making infections harder to treat and increasing morbidity, mortality, and healthcare costs globally.
- AMR is driven by antibiotic misuse in humans, livestock, and agriculture, plus pharmaceutical effluents and poor wastewater treatment infrastructure, especially in densely populated developing countries.
- Sewage surveillance captures community-level signals from households, hospitals, farms, and industries, offering early-warning insights into antibiotic use and resistance trends.
Scientific and technological dimension
- The dipstick works like a rapid diagnostic test, detecting amplified resistance genes from sewage DNA using PCR-based amplification and visible colour-band readouts.
- Each dipstick detects 16 resistance genes and provides results within two hours, enabling time-efficient, field-friendly surveillance without advanced laboratory infrastructure.
- The platform is upgradeable within three days if new resistance genes emerge globally, ensuring adaptability to evolving microbial threats.
Public health and governance dimension
- India is recognised as a global AMR hotspot by WHO, with high infectious disease burden and widespread antibiotic access without prescriptions.
- AMR threatens procedures like surgeries, chemotherapy, and organ transplants, where effective antibiotics are critical for infection prevention.
- Low-cost surveillance supports India’s National Action Plan on AMR (NAP-AMR) goals on monitoring and containment.
Economic dimension
- AMR could cause 10 million deaths annually by 2050 globally and reduce global GDP by 2–3.5%, according to international estimates.
- Affordable surveillance reduces long-term healthcare costs by enabling targeted interventions and rational antibiotic stewardship.
- Low-cost diagnostics are vital for LMICs, where high-end genomic surveillance is financially unsustainable.
Social and ethical dimension
- Sewage surveillance is considered ethically acceptable since it monitors communities anonymously without targeting individuals, avoiding privacy and consent concerns.
- Helps protect vulnerable populations who suffer disproportionately from drug-resistant infections due to limited healthcare access.
- Encourages a One Health approach, integrating human, animal, and environmental health.
Data and evidence
- Researchers analysed sewage from 381 locations across Assam, Haryana, Jharkhand, UP, Uttarakhand, and West Bengal, confirming widespread antibiotic residues and resistance genes.
- India has some of the highest antibiotic consumption rates globally, increasing selection pressure for resistant microbes.
- Only a fraction of wastewater in India undergoes effective treatment, facilitating AMR spread.
Limitations and cautions
- Detection of a gene signals possibility of resistance, not presence of a live pathogenic organism; genes alone do not cause disease.
- AMR expression varies by gene combinations and ecological context, requiring cautious interpretation.
- Dipsticks complement but do not replace culture-based and genomic surveillance.
Way forward
- Integrate dipstick surveillance into routine urban wastewater monitoring under public health and Jal Shakti frameworks.
- Link results to antibiotic stewardship programmes and regulation of pharmaceutical effluents.
- Expand AMR labs and genomic surveillance for confirmatory analysis.
- Strengthen wastewater treatment infrastructure under AMR containment strategy.
- Promote global data sharing aligned with WHO Global AMR Surveillance System (GLASS).


